Eswatini vs Indonesia: Average cost of tuberculosis treatment by type
Eswatini
15 constant 2022 US$
in 2024
Indonesia
17 constant 2022 US$
in 2024
Eswatini rank
36th
Indonesia rank
34th
Average cost of tuberculosis treatment by type over time
- Eswatini
- Indonesia
How they compare
Indonesia currently reports 17 constant 2022 US$ against 15 constant 2022 US$ in Eswatini, a difference of 2 constant 2022 US$.
That makes Indonesia's figure about 1.1 times Eswatini's.
The two have swapped places 3 times across 6 shared years of data; in 2019 it was Eswatini ahead.
Eswatini ranks 36th and Indonesia ranks 34th of 62 countries.
Across the 2 decades both report, Eswatini averaged higher in 1 and Indonesia in 1.
Head to head by decade
| Decade | Eswatini | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 16 constant 2022 US$ | 5 constant 2022 US$ | 11 constant 2022 US$ | Eswatini |
| 2020s | 26.2 constant 2022 US$ | 31 constant 2022 US$ | 4.8 constant 2022 US$ | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Eswatini or Indonesia?
- Indonesia, at 17 constant 2022 US$ against 15 constant 2022 US$ in Eswatini as of 2024.
- What is the difference in average cost of tuberculosis treatment by type between Eswatini and Indonesia?
- 2 constant 2022 US$, with Indonesia ahead.
- How many years of comparable data are there for Eswatini and Indonesia?
- 6 years are reported by both, from 2019 to 2024.
- How do Eswatini and Indonesia rank globally for average cost of tuberculosis treatment by type?
- Eswatini ranks 36th and Indonesia ranks 34th of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.